These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3279499)

  • 1. Adverse effects of the fluoroquinolones.
    Halkin H
    Rev Infect Dis; 1988; 10 Suppl 1():S258-61. PubMed ID: 3279499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical toxicological aspects of fluoroquinolones.
    Stahlmann R
    Toxicol Lett; 2002 Feb; 127(1-3):269-77. PubMed ID: 12052667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adverse effects of fluoroquinolones.
    Smith CR
    J Antimicrob Chemother; 1987 Jun; 19(6):709-11. PubMed ID: 3475267
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials.
    Tandan M; Cormican M; Vellinga A
    Int J Antimicrob Agents; 2018 Nov; 52(5):529-540. PubMed ID: 29702230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modern fluoroquinolones (ciprofoxacin, levofloxacin) and the treatment of skin and soft tissue infections].
    Iakovlev VP; Svetukhin AM; Blatun LA; Ukhin SA
    Antibiot Khimioter; 2004; 49(8-9):57-65. PubMed ID: 15727148
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
    Wilton LV; Pearce GL; Mann RD
    Br J Clin Pharmacol; 1996 Apr; 41(4):277-84. PubMed ID: 8730972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brodimoprim: adverse drug reactions from spontaneous reporting.
    Conforti A; Gugliemo L; Naldi L; Cocci A; Venegoni M; Leone R
    Br J Clin Pharmacol; 1997 Oct; 44(4):411. PubMed ID: 9354318
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety profile of the fluoroquinolones: focus on levofloxacin.
    Liu HH
    Drug Saf; 2010 May; 33(5):353-69. PubMed ID: 20397737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline.
    Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL
    Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
    Clark DW; Layton D; Wilton LV; Pearce GL; Shakir SA
    Drug Saf; 2001; 24(15):1143-54. PubMed ID: 11772147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of quinolone derivatives on theophylline clearance.
    Wijnands WJ; Vree TB; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Dec; 22(6):677-83. PubMed ID: 3567014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The quinolones in chronic bronchitis.
    Davies BI; Maesen FP; Teengs JP; Baur C
    Pharm Weekbl Sci; 1986 Feb; 8(1):53-9. PubMed ID: 3960693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety.
    Rodvold KA; Piscitelli SC
    Clin Infect Dis; 1993 Aug; 17 Suppl 1():S192-9. PubMed ID: 8399914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of fluoroquinolone safety.
    Wolfson JS; Hooper DC
    Am J Med; 1991 Dec; 91(6A):153S-161S. PubMed ID: 1767803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability of the newer fluoroquinolone antibacterials.
    Ball P; Mandell L; Niki Y; Tillotson G
    Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of the quinolones.
    Neu HC
    Lancet; 1987 Dec; 2(8571):1319-22. PubMed ID: 2890913
    [No Abstract]   [Full Text] [Related]  

  • 20. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
    Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.